We offer proprietary biomarkers focused on the identification and monitoring of disease in clinical trials, delivered as a turn-key medical imaging solution via a secure, cloud-based software as a service (SaaS).
Body composition analysis offers insights into the quality of weight loss聽and patient health. These powerful tools support decision-making in drug development across a broad spectrum of clinical trials (i.e.聽obesity, neuromuscular disorders, cancer cachexia).
Multi-organ services delivered through quantitative MRI and DXA to support obesity, metabolic, and neuromuscular disease-focused clinical trials.
Accurate and precise non-invasive imaging biomarkers for characterizing and monitoring treatment response.
Accurate and precise non-invasive imaging biomarkers for characterizing and monitoring treatment response.
Rapid, high-quality sample processing with a fully digitized reporting workflow and quantitative AI-pathology.
Integrated analysis of our noninvasive, multi-organ & tumor characterization software, digital pathology, and endoscopy, enables a deeper rapid analysis of the patient and their cancer.
Locations Worldwide
Research Partners
Papers Published
Interventional Trials
Trial Datasets Processed
In this episode of the AWS Health Innovation Podcast, Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at Amazon Web Services, sits down with Rajarshi Banerjee, aka 鈥楤anjo鈥, the CEO of, a company revolutionizing the way we diagnose and monitor chronic diseases.
Come visit us at one of the conferences listed to discuss your trial requirements